The results obtained by quantitative analysis of RARA and CRABP2 expression in the nephroblastoma samples showed median values of 24.2% per HMF (6.3%–40.3%) and 26.3% per HMF (4.2%–40.4%), respectively (Table 2). The gene discussed is CRABP2; the disease is Wilms tumor.